Barclays plc ADR (NYSE:BCS) does about 17.12M shares in volume on a normal day but saw 20700413 shares change hands in Monday trading. The company now has a market cap of 37.20B USD. Its current market price is $9.87, marking an increase of 1.33% compared to the previous close of $9.74. The 52 week high reached by this stock is $9.98 whilst the lowest price level in 52 weeks is $6.23.
Barclays plc ADR (BCS) has a 20-day trading average at $9.33 and the current price is -1.10% off the 52-week high compared with 58.43% distance from its 52-week low. The 50-day simple moving average of the closing price is $8.54 and its 200-day simple moving average is $7.76. If we look at the stock’s price movements over the week, volatility stands at 1.81%, which decreases to 1.65% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 75.01 to suggest the stock is overbought.
The consensus objective for the share price is $11.66, suggesting that the stock has a potential upside of 15.35% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 26, 2023 when BofA Securities downgraded the stock to “Underperform” and issued a price target of between $8.77 and $7.31.
Barclays plc ADR (BCS) stock is up 6.24% over the week and 9.42% over the past month. Its price is 25.25% year-to-date and 33.38% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/30/2023, with the company’s earnings per share (EPS) of $0.21 above consensus estimates by $0.34. BCS’s earnings per share are forecast to shrink by -8.70% this year and 18.40% over next year.
To reach the target analysts have set, the stock logically needs to grow 15.35 percent from here.
Outstanding shares total 3.79B with insiders holding 0.00% of the shares and institutional holders owning 4.15% of the company’s common stock. The company has a return on investment of 2.47% and return on equity of 7.57%. The forward price to earnings ratio is 5.22. The beta has a value of 1.48. Price to book ratio is 0.51 and price to sales ratio is 1.18.
